• 1. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 2. Fate of Sb(v) and Sb(iii) species along a gradient of pH and oxygen concentration in the Carnoulès mine waters (Southern France)
  Eléonore Resongles,Corinne Casiot,Fran?oise Elbaz-Poulichet,Rémi Freydier,Odile Bruneel,Christine Piot,Sophie Delpoux,Aurélie Volant,Angélique Desoeuvre Environ. Sci.: Processes Impacts, 2013,15, 1536-1544
• 3. Dissociative electron attachment to HGaF4 Lewis–Br?nsted superacid
  Marcin Czapla,Jack Simons Phys. Chem. Chem. Phys., 2018,20, 21739-21745
• 4. Emerging enantiomeric resolution materials with homochiral nano-fabrications
  Ji-Ping Wei Nanoscale, 2015,7, 11815-11832
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

Exploring the Versatile Applications of 2,3-Dimethylindazole-6-Carbonitrile (CAS No. 1234615-89-4) in Modern Chemistry

2,3-Dimethylindazole-6-carbonitrile (CAS No. 1234615-89-4) is a specialized heterocyclic compound that has garnered significant attention in pharmaceutical and material science research. This nitrogen-containing heterocycle features a unique molecular structure combining an indazole core with methyl substituents and a cyano group, making it valuable for various synthetic applications. Researchers particularly value its role as a versatile building block in medicinal chemistry, where it serves as a precursor for numerous biologically active molecules.

The growing interest in indazole derivatives like 2,3-dimethylindazole-6-carbonitrile stems from their remarkable pharmacological potential. Current trends in drug discovery emphasize the development of small molecule inhibitors targeting protein kinases, and this compound's structural features make it an excellent candidate for such applications. Its electron-withdrawing cyano group and methyl substitutions contribute to enhanced metabolic stability and improved binding affinity – two critical factors in modern drug design.

Beyond pharmaceutical applications, 2,3-dimethylindazole-6-carbonitrile shows promise in materials science. Its molecular architecture suggests potential utility in developing organic electronic materials, particularly as a component in OLED (organic light-emitting diode) technologies. The compound's conjugated system and electron-deficient character make it interesting for researchers exploring novel charge transport materials for next-generation displays and lighting solutions.

Synthetic chemists appreciate 2,3-dimethylindazole-6-carbonitrile for its relatively straightforward preparation from commercially available starting materials. The standard synthetic route typically involves cyclization reactions of appropriately substituted precursors, followed by cyanation reactions to introduce the nitrile functionality. Recent advances in catalytic cyanation methods have improved the efficiency of producing such compounds, addressing growing industrial demand.

The physicochemical properties of 2,3-dimethylindazole-6-carbonitrile contribute to its widespread utility. With moderate solubility in common organic solvents and good thermal stability, this compound handles well in various reaction conditions. Its molecular weight of 185.22 g/mol and balanced lipophilicity profile make it particularly suitable for medicinal chemistry applications where such parameters critically influence drug-like properties.

Recent patent literature reveals increasing interest in 2,3-dimethylindazole-6-carbonitrile derivatives as potential therapeutics for neurological disorders. Several research groups have reported promising activity of related compounds as modulators of neurotransmitter systems, particularly in targeting receptors implicated in anxiety and depression. This aligns with current pharmaceutical industry focus on central nervous system (CNS) drugs to address growing mental health concerns worldwide.

Quality control of 2,3-dimethylindazole-6-carbonitrile typically involves analytical techniques such as HPLC (High Performance Liquid Chromatography) and NMR spectroscopy. These methods ensure the compound meets the stringent purity requirements for research and development applications. The availability of high-purity material (typically >98%) from specialty chemical suppliers facilitates its adoption across various research programs.

Environmental and safety considerations for 2,3-dimethylindazole-6-carbonitrile follow standard laboratory chemical handling protocols. While not classified as hazardous under current regulations, proper personal protective equipment (PPE) including gloves and safety glasses is recommended when handling this compound. Storage under inert atmosphere at controlled temperatures helps maintain its stability over extended periods.

The commercial availability of 2,3-dimethylindazole-6-carbonitrile from multiple global suppliers reflects its growing importance in chemical research. Current market trends show steady demand from both academic institutions and pharmaceutical companies, with projected growth as more applications emerge in drug discovery pipelines and material science innovations.

Future research directions for 2,3-dimethylindazole-6-carbonitrile likely include exploration of its photophysical properties for optoelectronic applications and further investigation of its pharmacological potential. The compound's versatility ensures it will remain a valuable tool for chemists working across multiple disciplines, from medicinal chemistry to advanced materials development.

• 444731-72-0(2,3-Dimethyl-2H-indazol-6-amine)
• 267413-29-6(1-methylindazole-6-carbonitrile)
• 31748-44-4(1-methylindazole-3-carbonitrile)
• 58706-38-0(2H-Indazole, 2,3,7-trimethyl-)
• 189107-45-7(1-methylindazole-5-carbonitrile)
• 635702-60-2(2,3-Dimethyl-2H-indazol-6-amine hydrochloride)
• 31748-45-5(3-Cyano-2-methyl-2H-indazole)
• 1159511-43-9(1-Methyl-1H-indazole-4-carbonitrile)
• 1159511-45-1(2-methyl-2H-indazole-4-carbonitrile)
• 1015846-71-5(1,5-Dimethyl-1H-indazole-3-carbonitrile)